Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 May 12;17(1):115.
doi: 10.1186/s13019-022-01872-0.

Refractory post-thymectomy myasthenia gravis with onset at MGFA stage V: a case report

Affiliations
Case Reports

Refractory post-thymectomy myasthenia gravis with onset at MGFA stage V: a case report

Rui-Qin Zhou et al. J Cardiothorac Surg. .

Abstract

Background: Post-thymectomy myasthenia gravis (PTMG) is defined as thymoma patients without signs of myasthenia gravis (MG) pre-operation, but develop MG after radical surgical resection. PTMG might be misdiagnosed not only because of its rare incidence, but also the uncertain interval between the removal of thymoma and the new onset MG. Additionally, some surgeons and anesthesiologists pay less attention to those asymptomatic thymoma patients in perioperative management, leading to the neglect of new onset PTMG, and miss the best time to treat it.

Case presentation: Majority of cases of PTMG with onset at stage I-II on the basis of Myasthenia Gravis Foundation of America (MGFA) classification have been reported, but rarely at stage V, which requiring intubation or non-invasive ventilation to avoid intubation. Herein, we presented a 70-year-old male with PTMG onset at MGFA stage V, meanwhile, he had severe pulmonary infection interfering with the diagnosis of PTMG, and eventually progressed to refractory PTMG, which requiring much more expensive treatments and longer hospital stays.

Conclusion: In the perioperative management of asymptomatic thymoma patients, careful preoperative evaluation including physical examination, electrophysiological test and acetylcholine receptor antibodies (AChR-Ab) level should be done to identify subclinical MG. Complete resection should be performed during thymectomy, if not, additional postoperative adjuvant therapy is neccessary to avoid recurrence. It's important to identify PTMG at a early stage, especially when being interfered with by postoperative complications, such as lung infection, so that treatments could be initiated as soon as possible to avoid developing to refractory PTMG.

Keywords: Case report; Infection; Misdiagnose; Post-thymectomy myasthenia gravis; Thymoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interest.

Similar articles

Cited by

References

    1. Namba T, Brunner NG, Grob D. Myasthenia gravis in patients with thymoma, with particular reference to onset after thymectomy. Medicine. 1978;57(5):411–433. doi: 10.1097/00005792-197809000-00002. - DOI - PubMed
    1. Ito M, Fujimura S, Monden Y, et al. A retrospective group study on post-thymectomy myasthenia gravis. Nihon Kyobu Geka Gakkai. 1992;40(2):189–193. - PubMed
    1. Li J, Zhang DC, Wang LJ, Zhang DW, Zhang RG. Myasthenia gravis occurring after resection of thymoma. Chin J Surg. 2004;42(9):540–542. - PubMed
    1. Kondo K, Monden Y. Myasthenia gravis appearing after thymectomy for thymoma. Eur J Cardiothorac Surg. 2005;28(1):22–25. doi: 10.1016/j.ejcts.2005.03.039. - DOI - PubMed
    1. Nakajima J, Murakawa T, Fukami T, Sano A, Takamoto S, Ohtsu H. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody. Ann Thorac Surg. 2008;86(3):941–945. doi: 10.1016/j.athoracsur.2008.04.070. - DOI - PubMed

Publication types